Harold Edward Fleming - 05 Jun 2025 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Director
Signature: /s/ Elizabeth Ryland Waldinger
Issuer symbol: CRSP
Transactions as of: 05 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 06 Jun 2025, 17:30:19 UTC
Previous filing: 06 Feb 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fleming Harold Edward	Director	C/O CRISPR THERAPEUTICS, 105 WEST FIRST STREET, BOSTON	/s/ Elizabeth Ryland Waldinger	06 Jun 2025	0001857250

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Award	$0	+13K		$0.00	13K	05 Jun 2025	Common Shares	13K	$38.57	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.